Benextramine irreversibly inhibits [125I]neuropeptide Y affinity labeling of the Y2 binding protein in bovine hippocampus
- 25 May 1991
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 207 (1), 89-91
- https://doi.org/10.1016/s0922-4106(05)80042-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Benextramine: a long-lasting neuropeptide Y receptor antagonistEuropean Journal of Pharmacology, 1990
- Binding sites for 125I-neuropeptide Y (NPY) on membranes from bovine adrenal medullaEuropean Journal of Pharmacology, 1989
- Y1 and Y2 receptors for neuropeptide YFEBS Letters, 1989
- Characterization of Peptide YY Receptors in the BrainEndocrinology, 1989
- Neuropeptide Y as an autonomic neurotransmitterPharmacology & Therapeutics, 1988
- Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptidesRegulatory Peptides, 1986
- Two long acting α-adrenoceptor blocking drugs: benextramine and phenoxybenzamineTrends in Pharmacological Sciences, 1982
- Tetramine disulfides: a new tool in α-adrenergic pharmacologyTrends in Pharmacological Sciences, 1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970